Steris (STE) Revenue (2018 - 2026)

Steris' Revenue history runs 9 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• On a quarterly basis, Revenue rose 7.29% year-over-year to $1.6 billion in Q1 2026; TTM through Mar 2026 was $5.9 billion, a 8.73% increase from a year earlier, with the FY2026 full-year figure at $5.9 billion, up 8.73% from the prior year.
• Revenue climbed to $1.6 billion in Q1 2026 per STE's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Revenue topped out at $1.6 billion in Q1 2026 and bottomed at $1.1 billion in Q2 2022.
• The 5-year median for Revenue is $1.3 billion (2023), against an average of $1.3 billion.
• Biggest YoY gain for Revenue was 38.6% in 2022; the steepest drop was 8.86% in 2022.
• Year by year, Revenue stood at $1.1 billion in 2022, then gained by 16.66% to $1.3 billion in 2023, then rose by 5.62% to $1.4 billion in 2024, then gained by 9.16% to $1.5 billion in 2025, then increased by 6.16% to $1.6 billion in 2026.
• Per Business Quant, the three latest STE Revenue figures stand at $1.6 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025).